News Website

Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer - OncLive

Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer OncLive

Published: March 6, 2025, 2:32 p.m.

Read Full Article

Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer - Frontiers

Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer Frontiers

Published: March 4, 2025, 1:24 p.m.

Read Full Article

Dr Hinchcliff on the Benefits of Chemoimmunotherapy in Endometrial Cancer - OncLive

Dr Hinchcliff on the Benefits of Chemoimmunotherapy in Endometrial Cancer OncLive

Published: Feb. 21, 2025, 9:57 p.m.

Read Full Article

Dr Wagar on the Role of Adjuvant Immunotherapy in Endometrial Cancer - OncLive

Dr Wagar on the Role of Adjuvant Immunotherapy in Endometrial Cancer OncLive

Published: Feb. 13, 2025, 8:12 p.m.

Read Full Article

(PDF) Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment - ResearchGate

(PDF) Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment ResearchGate

Published: Jan. 25, 2025, 1:07 p.m.

Read Full Article

Unveiling Immunogenic Characteristics and Neoantigens in Endometrial Cancer with POLE Hotspot Mutations for Improved Immunotherapy - Frontiers

Unveiling Immunogenic Characteristics and Neoantigens in Endometrial Cancer with POLE Hotspot Mutations for Improved Immunotherapy Frontiers

Published: Jan. 6, 2025, 6:36 p.m.

Read Full Article

Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment - Frontiers

Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment Frontiers

Published: Dec. 24, 2024, 7:10 p.m.

Read Full Article

Immunotherapy Redefines Standard of Care for Frontline Advanced Endometrial Cancer - OncLive

Immunotherapy Redefines Standard of Care for Frontline Advanced Endometrial Cancer OncLive

Published: Dec. 5, 2024, 7:04 p.m.

Read Full Article

Immunotherapy May Be Underused in Endometrial Cancer - Cancer Therapy Advisor

Immunotherapy May Be Underused in Endometrial Cancer Cancer Therapy Advisor

Published: Nov. 20, 2024, 3:15 p.m.

Read Full Article

Nouscom's Off-the-Shelf Neoantigen Immunotherapy, NOUS-209, Continues to Elicit Potent and Durable Immune Responses in Lynch Syndrome Carriers Highlighting its Potential to 'Intercept' Cancer - The Manila Times

Nouscom's Off-the-Shelf Neoantigen Immunotherapy, NOUS-209, Continues to Elicit Potent and Durable Immune Responses in Lynch Syndrome Carriers Highlighting its Potential to 'Intercept' Cancer The Manila Times

Published: Nov. 5, 2024, 2:11 p.m.

Read Full Article

Latest Articles

Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer - OncLive

Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer - Frontiers

Dr Hinchcliff on the Benefits of Chemoimmunotherapy in Endometrial Cancer - OncLive

Dr Wagar on the Role of Adjuvant Immunotherapy in Endometrial Cancer - OncLive

(PDF) Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment - ResearchGate

Unveiling Immunogenic Characteristics and Neoantigens in Endometrial Cancer with POLE Hotspot Mutations for Improved Immunotherapy - Frontiers

Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment - Frontiers

Immunotherapy Redefines Standard of Care for Frontline Advanced Endometrial Cancer - OncLive

Immunotherapy May Be Underused in Endometrial Cancer - Cancer Therapy Advisor

Nouscom's Off-the-Shelf Neoantigen Immunotherapy, NOUS-209, Continues to Elicit Potent and Durable Immune Responses in Lynch Syndrome Carriers Highlighting its Potential to 'Intercept' Cancer - The Manila Times

Subscribe to Our Newsletter